Giunti Psychometrics Holding SpA (MIL:GPSY) 3-Year EBITDA Growth Rate: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:GPSY Giunti Psychometrics Holding SpA MIL:GPSY
13 GF Score
Price €4.45
View Full Analysis

What is Giunti Psychometrics Holding SpA 3-Year EBITDA Growth Rate?

Giunti Psychometrics Holding SpA MIL:GPSY -0.67% 13 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus rates MIL:GPSY with a GF Score™ of 13/100. Among 688 Medical Devices & Instruments companies, Giunti Psychometrics Holding SpA ranks worse than 145348.69% on this metric.

Giunti Psychometrics Holding SpA's EBITDA per Share for the six months ended in Dec. 2025 was €0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Giunti Psychometrics Holding SpA  (MIL:GPSY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Giunti Psychometrics Holding SpA 3-Year EBITDA Growth Rate Related Terms

MIL:GPSY vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison

For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giunti Psychometrics Holding SpA 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Giunti Psychometrics Holding SpA's 3-Year EBITDA Growth Rate falls into.


MIL:GPSY
13GF Score
Giunti Psychometrics Holding SpA MIL:GPSY
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Giunti Psychometrics Holding SpA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Giunti Psychometrics Holding SpA (MIL:GPSY) has a 3-Year EBITDA Growth Rate of 0.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Giunti Psychometrics Holding SpA and its competitors. According to the industry distribution chart, Giunti Psychometrics Holding SpA ranks #999999 out of 688 companies in the Medical Devices & Instruments industry.
Is Giunti Psychometrics Holding SpA's 3-Year EBITDA Growth Rate too high?
Giunti Psychometrics Holding SpA's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Giunti Psychometrics Holding SpA ranks #999999 out of 688 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Giunti Psychometrics Holding SpA ranks #999999 out of 688 companies for 3-Year EBITDA Growth Rate. This places Giunti Psychometrics Holding SpA in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.90, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Giunti Psychometrics Holding SpA and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giunti Psychometrics Holding SpA's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (MIL:GPSY) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Giunti Psychometrics Holding SpA's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (MIL:GPSY), the current 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Giunti Psychometrics Holding SpA Business Description

Address Via Fra Paolo Sarpi 7/A, Firenze, ITA, 50136
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
13GF Score

Get the complete analysis for MIL:GPSY

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.45
Price